英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
WAY-313318 |
苯并三唑-1-基甲基-(2,3-二氯-苯基)-胺 |
351993-88-9 |
詳細(xì)
|
WAY-659873 |
5-氟-N-(3-(嗎啉磺?;?苯基)苯并[B]噻吩-2-甲酰胺 |
868268-81-9 |
詳細(xì)
|
p-Nitrobenzyl mesylate |
4-硝基芐基甲磺酸酯 |
39628-94-9 |
詳細(xì)
|
TTBK1-IN-2 |
化合物TTBK1-IN-2 |
2765453-51-6 |
詳細(xì)
|
HC-067047 |
883031-03-6 |
883031-03-6 |
詳細(xì)
|
OAC3 |
N-(4-Fluorobenzoyl)-5-aMino-1H-indole |
182564-41-6 |
詳細(xì)
|
MDL 72222;Tropanyl3,5-dichlorobenzoate |
貝美司瓊 |
40796-97-2 |
詳細(xì)
|
4-[[4-[(4-BROMO-2,6-DIMETHYLPHENYL)AMINO]-2-PYRIDIDINYL]AMINO]-BENZONITRILE |
利匹韋林中間體Despropenenitrile Bromo Rilpivirine |
374067-85-3 |
詳細(xì)
|
OTAVA-BB 7070707032 |
cFMS受體抑制劑IV |
959626-45-0 |
詳細(xì)
|
WAY-639729 |
5-Methyl-4-phenyl-2-(2-thienyl)thiazole |
113214-30-5 |
詳細(xì)
|
EKI-785; CL-387785 |
CL-387785 |
194423-06-8 |
詳細(xì)
|
Si ma-1 receptor anta onist 2 |
Sigma-1 receptor antagonist 2 |
1639220-15-7 |
詳細(xì)
|
WAY-639228-A |
N-(1-芐基哌啶-4-基)萘-2-磺酰胺 |
179051-05-9 |
詳細(xì)
|
WAY-608119 |
2-吡啶-3-基-1H-喹唑啉-4-酮 |
50362-93-1 |
詳細(xì)
|
WAY-354436 |
1-(1-芐基哌啶-4-基)-3-(2-氟苯基)硫脲 |
850023-52-8 |
詳細(xì)
|
BPTF-IN-BZ1 |
化合物 BPTF-IN-BZ1 |
2766623-38-3 |
詳細(xì)
|
WAY-621924 |
N-(4-甲基噻唑-2-基)-3-苯氧基苯甲酰胺 |
745789-70-2 |
詳細(xì)
|
PQM130 |
PQM130 |
2089415-51-8 |
詳細(xì)
|
Olvanil |
奧伐尼 |
58493-49-5 |
詳細(xì)
|
WAY-300570 |
(E)-N-(4-氯苯基)-3-(4-氧代-5-(噻吩-2-基亞甲基)-2-硫代噻唑啉-3-基)丙酰胺 |
308295-11-6 |
詳細(xì)
|
YM17E |
124900-72-7 |
124900-72-7 |
詳細(xì)
|
WAY-299905 |
3,3-二甲基-11-(4-硝基苯基)-2,3,4,5,10,11-六氫-1H-二苯并[B,E][1,4]二氮雜卓-1-酮 |
82408-04-6 |
詳細(xì)
|
Cdk1 Inhbitor |
Cdk1 Inhibitor |
220749-41-7 |
詳細(xì)
|
SLC13A5-IN-1 |
SLC13A5-IN-1 |
2227548-95-8 |
詳細(xì)
|
SSAA09E3 |
化合物SSAA09E3 |
52869-18-8 |
詳細(xì)
|
WAY-622024 |
化合物WAY-622024 |
291528-35-3 |
詳細(xì)
|
IHR 1 |
2,5-dichloro-N-[4-[(2,5-dichlorobenzoyl)amino]phenyl]benzamide |
548779-60-8 |
詳細(xì)
|
WAY-639872 |
WAY-639872 |
796119-18-1 |
詳細(xì)
|
NF-56-EJ40 |
NF-56-EJ40 |
2380230-73-7 |
詳細(xì)
|
WAY-620521 |
N-(萘-2-基)-2,3-二氫苯并[B][1,4]二噁烷-6-磺酰胺 |
315693-33-5 |
詳細(xì)
|
WAY-304671 |
N-(苯并[D]噻唑-2-基)-3-氯苯并[B]噻吩-2-甲酰胺 |
330837-95-1 |
詳細(xì)
|
WAY-312084 |
化合物 WAY-312084 |
335209-06-8 |
詳細(xì)
|
Ani9 |
Ani9 |
356102-14-2 |
詳細(xì)
|
WAY-640582 |
N-(9-乙基-9H-咔唑-3-基)-5-甲基異惡唑-3-甲酰胺 |
322723-35-3 |
詳細(xì)
|
WAY-608106-A |
N-芐基-2-(4-苯丙烯基哌嗪-1-基)乙酰胺 |
685137-44-4 |
詳細(xì)
|
WAY-634964 |
5-硝基-2-(1H-吡咯-1-基)吡啶 |
157842-34-7 |
詳細(xì)
|
KCC009 |
Benzyl (S)-1-((3-BroMo-4,5-Dihydroisoxazol-5-Yl)MethylaMino)-3-(4-Hydroxyphenyl)-1-Oxopropan-2-YlcarbaMate |
744198-19-4 |
詳細(xì)
|
WAY-313165 |
N-環(huán)辛基-2-(對(duì)甲苯氧基)乙酰胺 |
332399-50-5 |
詳細(xì)
|
WAY-119918 |
3-(吡咯烷-1-基)-N-(對(duì)甲苯基)丙酰胺 |
428831-87-2 |
詳細(xì)
|
NC C00229600 |
4(1H)-Quinazolinone, 2-[3-[(2,6-diMethylphenoxy)Methyl]-4-Methoxyphenyl]-2,3-dihydro-3-(3-pyridinylMethyl)- |
1338824-20-6 |
詳細(xì)
|
WAY-354574 |
3-(氮雜環(huán)庚烷-1-基磺酰基)-N-(3-氯芐基)苯甲酰胺 |
851873-40-0 |
詳細(xì)
|
EF24 |
3,5-Bis[(2-fluorophenyl)Methylene]-4-piperidinone |
342808-40-6 |
詳細(xì)
|
Si ma-1 receptor anta onist 3 |
Sigma-1 receptor antagonist 3 |
1639220-17-9 |
詳細(xì)
|
MRT 10 |
N-[[[3-[(Benzoyl)amino]phenyl]amino](thioxo)methyl]-3,4,5-trimethoxybenzamide |
330829-30-6 |
詳細(xì)
|
FDI-6 |
SALOR-INT L224693-1EA |
313380-27-7 |
詳細(xì)
|
WAY-660222 |
1-(2-氟苯基)-3-(萘-2-基)丙-2-烯-1-酮 |
867294-23-3 |
詳細(xì)
|
C P 35348 |
(3-氨丙基)(二乙氧基甲基)膦酸水合物 |
123690-79-9 |
詳細(xì)
|
Si ma-1 receptor anta onist 1 |
Sigma-1 receptor antagonist 1 |
1639220-19-1 |
詳細(xì)
|
P- p inhibitor 1 |
P-GP INHIBITOR 1 |
2050747-49-2 |
詳細(xì)
|
WAY-299765 |
3-(2-甲基噻唑-4-基)-2H-苯并吡喃-2-酮 |
106578-02-3 |
詳細(xì)
|
WAY-604603 |
2-(2-(4-氯苯基)-2-氧代乙基)苯并[D]異噻唑-3(2H)-酮 1,1-二氧化物 |
41335-62-0 |
詳細(xì)
|
WAY-639698 |
2-硝基-N-(4-(吡啶-2-基)噻唑-2-基)苯甲酰胺 |
476317-29-0 |
詳細(xì)
|
CALCIUM IONOPHORE II |
鈣離子載體 II |
74267-27-9 |
詳細(xì)
|
WAY-643895 |
N-(3-氰基噻吩-2-基)吡啶-2-甲酰胺 |
851871-94-8 |
詳細(xì)
|
PKR-IN-C51 |
化合物 T24647 |
1314594-23-4 |
詳細(xì)
|
WAY-351783 |
N-(6-乙?;讲D][1,3]二氧戊環(huán)-5-基)-2-溴苯磺酰胺 |
460994-47-2 |
詳細(xì)
|
WAY-652509 |
化合物WAY-652509 |
854355-54-7 |
詳細(xì)
|
UNC 1079 |
1,4-伸苯基雙(1,4'-二哌啶-1'-基甲酮) |
1418741-86-2 |
詳細(xì)
|
Methoxy-X04 |
Methoxy-X04 |
863918-78-9 |
詳細(xì)
|
Thiethylperazine Maleate |
馬來(lái)酸乙?guī)€拉嗪 |
1179-69-7 |
詳細(xì)
|
WAY-608094 |
WAY-608094 |
312590-55-9 |
詳細(xì)
|
Afobazole (hydrochloride) |
CS-1292 |
173352-39-1 |
詳細(xì)
|
TMPA |
1258275-73-8 |
1258275-73-8 |
詳細(xì)
|
PI3K/mTOR Inhibitor-2 |
PI3K/mTOR 抑制劑-2 |
1848242-58-9 |
詳細(xì)
|
WAY-350568 |
(4-(嘧啶-2-基)哌嗪-1-基)(2-(對(duì)甲苯基)喹啉-4-基)甲酮 |
546100-66-7 |
詳細(xì)
|
UNC 1021 |
化合物UNC?1021 |
1322591-19-4 |
詳細(xì)
|
Thiethylperazine |
乙?guī)€匹拉嗪 |
1420-55-9 |
詳細(xì)
|
BI-6015 |
BI-6015 |
93987-29-2 |
詳細(xì)
|
WAY-601035 |
2-氨基-5-(喹啉-6-亞甲基)噻唑-4(5H)-酮 |
304645-61-2 |
詳細(xì)
|
Cystamine |
胱胺 |
51-85-4 |
詳細(xì)
|
WAY-616296 |
(Z)-5-(3-(芐氧基)亞芐基)-2-硫代咪唑烷-4-酮 |
503065-67-6 |
詳細(xì)
|
Necrosis Inhibitor, IM-54 |
Necrosis Inhibitor, IM-54 |
861891-50-1 |
詳細(xì)
|
WAY-328229 |
(2,6-二甲基哌啶-1-基)(5-(4-甲氧基苯基)異惡唑-3-基)甲酮 |
912777-95-8 |
詳細(xì)
|
WAY-606376 |
WAY-606376 |
522639-94-7 |
詳細(xì)
|
p38-α MAPK-IN-1 |
443913-15-3 |
443913-15-3 |
詳細(xì)
|
WAY-381644 |
N-((3-(N-(2-氯苯基)氨磺?;?-4-甲基苯基)硫代甲脒基)-4-氟苯甲酰胺 |
379713-58-3 |
詳細(xì)
|
TK216 |
TK216 |
1903783-48-1 |
詳細(xì)
|
FPR A14 |
1,3-BENZODIOXOLANE-5-CARBOXYLIC ACID 4'-BENZYLOXY-3'-METHOXYBENZYLIDENE HYDRAZIDE |
329691-12-5 |
詳細(xì)
|
NMS-859 |
1449236-96-7 |
1449236-96-7 |
詳細(xì)
|
5H-Pyrazolo[3,4-b]quinolin-5-one, 1,4,6,7,8,9-hexahydro-3,7,7-trimethyl-4-(3-pyridinyl)- |
3,7,7-三甲基-4-吡啶-3-基-6,7,8,9-四氫吡唑并[1,3-B]喹啉-4(5H)酮 |
748145-19-9 |
詳細(xì)
|
WAY-215718 |
WAY-215718 |
128175-06-4 |
詳細(xì)
|
WAY-324197 |
6-苯基-5,6,6A,7,8,9,10,10A-八氫-7,10-甲橋菲啶-2-甲酰胺 |
1005095-06-6 |
詳細(xì)
|
WAY-329600 |
4-(3,5-二甲基-1H-吡唑-1-基)-N-(4-甲基噻唑-2-基)苯甲酰胺 |
956959-79-8 |
詳細(xì)
|
WAY-325485 |
化合物 WAY-325485 |
177937-81-4 |
詳細(xì)
|
1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, monosodium salt |
AllopurinolSodium別嘌醇鈉 |
17795-21-0 |
詳細(xì)
|
WAY-620147 |
WAY-620147 |
515866-67-8 |
詳細(xì)
|
WAY-328127 |
N-環(huán)戊基-5-(4-氟苯基)異惡唑-3-甲酰胺 |
912784-67-9 |
詳細(xì)
|
WAY-325811 |
2-甲基-N-(4-(4-丙基苯基)噻唑-2-基)呋喃-3-甲酰胺 |
869632-12-2 |
詳細(xì)
|
WAY-328158 |
N-(3-氨基-4,5,6,7-四氫苯并[B]噻吩-2-基)-5-(4-氟苯基)異惡唑-3-甲酰胺 |
688050-42-2 |
詳細(xì)
|
WAY-313201 |
2-((5-(2-氟苯基)-1,3,4-惡二唑-2-基)硫基)-1-(吲哚啉-1-基)乙酮 |
571904-77-3 |
詳細(xì)
|
CL-300619 |
2-苯基-5,6,7,8-四氫苯并[4,5]噻吩并[2,3-D]嘧啶-4(3H)-酮 |
19819-18-2 |
詳細(xì)
|
WAY-296712 |
N-(2-羥基苯基)吡啶-2-甲酰胺 |
88530-99-8 |
詳細(xì)
|
SB 328437 |
(S)-METHYL-2-NAPHTHOYLAMINO-3-(4-NITROPHENYL)PROPIONATE |
247580-43-4 |
詳細(xì)
|
WAY-655978 |
2-(2-氯苯基)-N-(4-(吡啶-4-基)噻唑-2-基)乙酰胺 |
692869-98-0 |
詳細(xì)
|
WAY-637845 |
PZYDJAWERUKJRG-UHFFFAOYSA-N |
794539-14-3 |
詳細(xì)
|
WAY-648936 |
2-(3-(4-(2-羥乙基)哌嗪-1-基)-3-氧代丙基)異吲哚啉-1,3-二酮 |
796888-73-8 |
詳細(xì)
|
WAY-658650 |
化合物WAY-658650 |
476319-66-1 |
詳細(xì)
|
WAY-638127 |
N-(2-甲氧基芐基)-5-硝基呋喃-2-甲酰胺 |
313981-44-1 |
詳細(xì)
|
KDM2B-IN-2 |
化合物KDM2B-IN-2 |
1965248-01-4 |
詳細(xì)
|
WAY-352753 |
2-((2-氯芐基)硫基)-5-(吡啶-4-基)-1,3,4-惡二唑 |
478482-74-5 |
詳細(xì)
|